Symposiums

The therapeutic landscape for hormone receptor-positive (HR+) advanced breast cancer (BC) is moving from generalized endocrine therapies…

Patients with cancer often have a compromised immune system, which places them at an increased risk of infection that can extend beyond…

Mutations in HER2, also known as ERBB2, represent a distinct molecular subset of NSCLC, occurring in approximately 2–4% of cases, and are…

EpNECs are considered rare and are often associated with a poor prognosis, with up to 85% of patients presenting with advanced…

Psoriasis is a common, chronic, inflammatory skin disease characterized by accelerated epidermal proliferation. The most common subtype is…

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania and Cambier…

Bronchiectasis is a chronic and progressive inflammatory lung disease, characterized by permanent and abnormal dilatation of the bronchi…

New analysis reveals nivolumab’s impact on disease-free survival in high-risk muscle-invasive bladder cancer.